Call : 818-262-3537
Skip to main content
Key Points
  • NIDA classifies addiction as a chronic brain disorder with relapse rates (40-60%) comparable to hypertension, diabetes, and asthma.
  • The most common relapse causes are untreated dual diagnosis, inadequate aftercare, PAWS, and unaddressed social/environmental triggers.
  • Post-Acute Withdrawal Syndrome (PAWS) can persist for weeks to months and is one of the most underappreciated relapse causes.
  • The highest-risk relapse period is the first 30-90 days post-discharge, especially the first 2 weeks.
  • CBT-based relapse prevention combined with Mindfulness-Based Relapse Prevention (MBRP) significantly reduces relapse rates at 12-month follow-up.
  • iRely Recovery starts aftercare and discharge planning during week one of residential treatment, not at discharge.

Relapse after rehab is one of the most misunderstood aspects of addiction recovery. Many people, and many families, experience a relapse as evidence that treatment failed, or worse, that the person is incapable of sustained recovery. Neither conclusion is accurate. Understanding the clinical relapse causes behind post-treatment substance use, and what effective relapse prevention looks like, fundamentally changes how you approach the recovery process.

NIDA characterizes addiction as a chronic brain disorder with relapse rates comparable to other chronic medical conditions such as hypertension (40-60%), type 2 diabetes (30-50%), and asthma (50-70%). Relapse, like a return of symptoms in any chronic disease, is clinically expected in a significant proportion of cases. This does not mean relapse is inevitable, acceptable, or without consequences. It means that understanding relapse causes is essential clinical work, not a reason for despair.

This guide covers the primary relapse causes identified in addiction research, the early warning signs that precede most relapses, and how iRely Recovery’s residential treatment program builds relapse prevention skills before discharge.

The Primary Relapse Causes in Addiction Recovery

Unaddressed Dual Diagnosis Conditions

One of the most frequently cited relapse causes is the presence of an undiagnosed or inadequately treated co-occurring mental health condition. Research from SAMHSA shows that over 9 million adults in the United States have both a substance use disorder and a co-occurring mental health disorder. When only the substance use is treated and the underlying depression, anxiety, PTSD, or bipolar disorder remains active, the likelihood of relapse increases dramatically.

This is why iRely Recovery’s dual diagnosis treatment model assesses and addresses co-occurring conditions from the first day of admission. Treatment that isolates addiction from the mental health factors that drive and sustain it addresses symptoms without addressing the underlying relapse causes.

Inadequate Aftercare and Step-Down Planning

Completing a residential program without a structured step-down plan is one of the most common relapse causes. The transition from the contained, supportive environment of residential treatment back to daily life, with its stressors, social networks, and practical demands, is a high-risk period for relapse. Research consistently shows that clients who transition directly from residential to intensive outpatient or standard outpatient care have significantly lower relapse rates than those who complete residential treatment and return immediately to unsupported daily life.

iRely Recovery’s aftercare program is developed during the residential phase, not after discharge. By the time a client leaves our program, a structured step-down plan is already in place, reducing the gap in clinical support that drives many post-treatment relapses.

Post-Acute Withdrawal Syndrome (PAWS)

Post-acute withdrawal syndrome (PAWS) is a cluster of protracted withdrawal symptoms, including mood instability, cognitive fog, sleep disruption, anxiety, and reduced stress tolerance, that can persist for weeks to months after the acute withdrawal phase. PAWS is one of the most clinically underappreciated relapse causes because many clients (and their families) do not expect to feel this way weeks after treatment and interpret these symptoms as evidence that they cannot function without substances.

At iRely Recovery, PAWS education is integrated into the treatment curriculum before discharge. Clients leave with a clear understanding of what PAWS is, what to expect, and how to manage symptoms without returning to substance use. This education transforms a silent relapse cause into a manageable clinical challenge.

Social and Environmental Triggers

People, places, and things associated with past substance use are powerful relapse causes that operate partly below conscious awareness. Neurologically, substance-paired cues activate the brain’s reward circuitry and produce cravings before the conscious mind has time to intervene. Returning to social networks, neighborhoods, or environments strongly associated with active use significantly increases relapse risk in early recovery.

Effective relapse prevention work includes systematic identification of personal trigger patterns and the development of concrete, practiced responses. This is not about avoiding the entire world. It is about building the cognitive and behavioral tools to respond effectively when triggers are encountered.

Why iRely Recovery Builds Relapse Prevention into Every Treatment Plan

CBT-Based Relapse Prevention Curriculum Delivered in Individual and Group Settings

Cognitive behavioral therapy is the gold standard evidence-based treatment for relapse prevention. iRely Recovery integrates CBT into both individual therapy and group therapy sessions throughout the residential treatment episode. CBT relapse prevention work focuses on identifying automatic thoughts that precede use, restructuring cognitive distortions that rationalize relapse, building behavioral coping strategies for high-risk situations, and developing a written personalized relapse prevention plan before discharge.

The dual-format delivery of this curriculum, in both individual and group settings, reinforces learning through multiple contexts and allows clients to test coping strategies in a safe, supervised environment before applying them in the real world.

Mindfulness-Based Relapse Prevention (MBRP) for Craving Management

iRely Recovery’s mindfulness-based therapy component incorporates Mindfulness-Based Relapse Prevention (MBRP), a clinically validated protocol developed by Dr. Sarah Bowen at the University of Washington. MBRP teaches clients to observe cravings as passing mental events rather than commands that must be obeyed. This skill, sometimes called “urge surfing,” directly addresses one of the primary relapse causes by building the pause between craving and action that allows for conscious choice.

Research published in JAMA Psychiatry shows that MBRP significantly reduces relapse rates compared to standard treatment at 12-month follow-up, particularly for clients with high levels of negative affect, which is one of the most common relapse causes in the post-treatment period.

Discharge Planning That Begins at Week One

At iRely Recovery, aftercare and discharge planning are not last-minute administrative tasks. They are clinical priorities that begin in the first week of residential treatment. By the time a client completes the program, their step-down care plan, outpatient therapy schedule, support group connections, aftercare program enrollment, and crisis response plan are already in place and practiced.

This front-loaded approach to discharge planning closes the gap that is one of the most preventable relapse causes: the absence of structured support in the immediate post-discharge period.

Getting Back on Track After Relapse

If a relapse has already occurred, the most important thing to understand is that recovery is still possible. Relapse is not failure. It is clinical information about what additional work is needed. The response to relapse should be prompt re-engagement with treatment, not shame-driven withdrawal from care.

If you or your loved one has relapsed after a previous treatment episode and needs to return to residential care, call iRely Recovery at (818) 262-3537. Our admissions team can assess what level of care is clinically appropriate and arrange rapid admission if indicated.

Healthcare providers: iRely Recovery accepts re-admissions and second-episode residential referrals. Our individualized treatment planning approach ensures that returning clients receive a treatment plan that reflects what was learned from the previous episode and addresses the specific relapse causes that contributed to the return to use.

Frequently Asked Questions

Below are some of the most frequently asked questions regarding these two medications.

No. Relapse is a clinically recognized component of the recovery process for many individuals with substance use disorder, comparable to symptom recurrence in other chronic diseases. NIDA data shows relapse rates of 40-60% for substance use disorder, similar to other chronic conditions. Relapse does not mean treatment failed. It means additional clinical work is needed, which is available and effective.

The highest-risk period for relapse is the first 30 to 90 days after completing residential treatment, particularly the first two weeks following discharge. This is why direct step-down to intensive outpatient care is strongly recommended rather than returning immediately to an unsupported daily routine. After the first 90 days, risk does not disappear, but it does decrease significantly with each additional month of sustained recovery.

The most common early relapse warning signs include increasing romanticization of past substance use, isolation from support networks, skipping therapy or support group meetings, increased stress without coping strategies, irritability or emotional volatility, and ‘testing’ sobriety by spending time in environments associated with past use. Recognizing these signs early allows for clinical intervention before full relapse occurs.

For some individuals, long-term recovery is maintained without any return to substance use. For others, one or more episodes of relapse occur before sustained recovery is achieved. Comprehensive treatment that addresses dual diagnosis, builds evidence-based coping skills, provides structured aftercare, and prepares clients for PAWS significantly reduces relapse risk. While relapse cannot be guaranteed absent in all cases, the risk can be substantially reduced through rigorous clinical care.

Whether a return to residential treatment is clinically indicated depends on the severity and duration of the relapse, the person’s current safety, the presence of physical dependence requiring medical detox, and the clinical factors that contributed to the relapse. A clinical assessment by an addiction medicine professional is the appropriate way to determine the right level of care after relapse. Call iRely Recovery at (818) 262-3537 for a clinical consultation.

Sources

iRely Recovery Editorial Policy

When you choose to walk with us on your journey to recovery, you deserve information that lifts you up rather than weighs you down. Our Editorial Policy ensures that all content we produce is crafted to put clarity, credibility, and compassionate context in your hands. Resources are written by or in collaboration with industry professionals and receive additional medical review to ensure accuracy.

Read More About Our Process

Call iRely Recovery Alcohol & Drug Rehab

Reach out to the iRely team and ask all of your questions. This is the new beginning you’ve been waiting for. Let’s lean in together.
Contact Us